Pheochromocytoma complicated with cardiomyopathy after delivery--a case report and literature review.
- Author:
Hyun Joong KIM
1
;
Duk Kyung KIM
;
Sang Chul LEE
;
Soon Ha YANG
;
Jung Hyun YANG
;
Won Ro LEE
Author Information
1. Department of Medicine, Samsung Medical Center, SungKyunKwan University College of Medicine, Seoul, Korea.
- Publication Type:Review ; Case Report
- MeSH:
Adrenal Gland Neoplasms/surgery;
Adrenal Gland Neoplasms/diagnosis*;
Adrenal Gland Neoplasms/complications;
Adult;
Cardiovascular Agents/therapeutic use;
Disease-Free Survival;
Echocardiography;
Electrocardiography;
Female;
Human;
Myocardial Diseases/ultrasonography;
Myocardial Diseases/etiology*;
Myocardial Diseases/drug therapy;
Pheochromocytoma/surgery;
Pheochromocytoma/diagnosis*;
Pheochromocytoma/complications;
Pregnancy;
Pregnancy Complications, Cardiovascular/etiology*;
Pregnancy Complications, Neoplastic/surgery;
Pregnancy Complications, Neoplastic/diagnosis*;
Pregnancy Outcome*;
Puerperium;
Tomography, X-Ray Computed;
Substances: Cardiovascular Agents
- From:The Korean Journal of Internal Medicine
1998;13(2):117-122
- CountryRepublic of Korea
- Language:English
-
Abstract:
Pheochromocytoma in pregnancy is very rare but it is associated with very high maternal and fetal mortality. Therefore, it is important to include pheochromocytoma in the differential diagnosis of hypertension associated with pregnancy. It is difficult to make a diagnosis of pheochromocytoma in pregnancy before delivery. The characteristic symptoms of pheochromocytoma could be initiated during delivery because the process of delivery, general anesthesia, fetal movement, induce acute surge of catecholamine release, which could also induce cardiomyopathy. Early diagnosis and intensive care can affect the prognosis of cardiomyopathy induced by pheochromocytoma. Proper management with alpha-blockade, beta-blockade and angiotension converting enzyme inhibitor could acutely reverse the course of cardiomyopathy.
